{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-013555","form_type":"8-K","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2022-05-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.483520+00:00","generated_at":"2026-06-25T07:08:22.426630+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"SVP of Clinical Operations Harry Alcorn resigns from DiaMedica; separation agreement includes salary continuation","bullets":["Harry Alcorn, Jr., Pharm.D., SVP of Clinical Operations, resigned effective May 23, 2022.","Separation agreement provides salary continuation for 9 months (up to 12 if unemployed), COBRA, pro-rata bonus, and option acceleration.","Entered consulting agreement at $200/hour; no fees while receiving salary continuation.","Alcorn must cooperate with transition, maintain confidentiality, and non-disparagement."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-013555","json":"https://secwatch.observer/filing/0001437749-22-013555.json","markdown":"https://secwatch.observer/filing/0001437749-22-013555.md","text":"https://secwatch.observer/filing/0001437749-22-013555.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774922013555/0001437749-22-013555-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774922013555/dmtp20220524_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T07:08:22.426630+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01b06aec5d","claim":"Harry Alcorn, Jr. resigned as Senior Vice President of Clinical Operations at DiaMedica Therapeutics Inc..","evidence_excerpt":"On May 23, 2022, Harry Alcorn, Jr., Pharm.D., Senior Vice President of Clinical Operations of DiaMedica Therapeutics Inc. (the “Company”), resigned as an officer and employee of the Company and its subsidiaries, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774922013555/0001437749-22-013555-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Senior Vice President of Clinical Operations"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}